Navigation Links
Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
Date:2/8/2011

strategy and filings for r-hGH (Norditropin®), targeting a growth deficiency in children indication, and r-FVIIa (NovoSeven®), targeting a hemophilia indication. Mr. Rosania has an M.S. degree in Chemistry from Drexel University and an M.S. degree in Organizational Dynamics from The University of Pennsylvania.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has one Phase 3 clinical program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as sPLA2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease (CAD). Anthera's Phase 2 product candidate, A-623, targets elevated levels of B-lymphocyte stimulator (BAFF) which has been associated with a variety of B-Cell mediated autoimmune diseases, including systemic lupus erythematosus (lupus). For more information, please visit www.anthera.com.

Safe Harbor Statement

Certain statements contained in this press release that refer to future events are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Anthera's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially as set forth in the Company's public filings with the Securities and Exchange Commission, including Anthera's Quarterly Report on Form 10-Q for the quarter ended September 30, 2010. Anthera disclaims any intent or obligation to
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
2. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
3. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
4. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
5. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
6. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
7. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
10. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
11. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... ZURICH , June 3, 2015 ... information is the Internet. As markets become ever more ... a fact Haselmeier AG recognised long ago. Its maxim ... new standards in networking and digitisation. The ... for its pioneering "state of the art" technology and ...
(Date:6/2/2015)...  University Hospitals (UH) Case Medical Center is ... area to implant a new miniaturized, wireless monitoring sensor to ... first and only FDA-approved heart failure monitoring device that has ... physicians to manage heart failure., The ... the pulmonary artery (PA) during a non-surgical procedure to directly ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/d8nj6b/europe ) has announced ... Growth, Trends And Forecasts (2014 - 2019)" report ... Fluoroscopy is expected to grow at a healthy CAGR ... to view the gastrointestinal tract, to direct the movement ... the urinary system, to open narrowed or blocked blood ...
Breaking Medicine Technology:UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 2UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 3European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2
... , VIENNA , July 19 "This is a ... first clinical evidence that a microbicide gel can help to prevent sexual ... reacting to the results of the landmark microbicide trial presented today at ... , , ...
... Fox Insurance Company agreed July 9 ... Medicare Part D prescription drug claims to the administrators of ... is currently closing claims and beginning to process payments for ... in order to provide long-awaited reimbursements to independent community pharmacies ...
Cached Medicine Technology:AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 2AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 3AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides 4Fox Insurance Agrees to Pay Delinquent Medicare Part D Claims After Action by Senators Baucus, Grassley, CMS and NCPA 2Fox Insurance Agrees to Pay Delinquent Medicare Part D Claims After Action by Senators Baucus, Grassley, CMS and NCPA 3Fox Insurance Agrees to Pay Delinquent Medicare Part D Claims After Action by Senators Baucus, Grassley, CMS and NCPA 4
(Date:6/3/2015)... “ Scanalytics ” was featured on NewsWatch as ... latest and coolest technology products available to consumers. Andrew ... conducted the review and shared with viewers how this ... stores. , Tracking statistics in business is invaluable in ... retail this goes a step beyond revenue statistics and ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Foot ... Dr. Casey Friske ( Clarksville Division ) ... from the Symposium of Advanced Wound Care (SAWC) and ... President-Elect Dr. Dan Davis. The Conference was held ... Gonzalez Convention Center in San Antonio, TX. , ...
(Date:6/3/2015)... Netherlands (PRWEB) June 03, 2015 Unfortunately, a ... when it comes to providing comfort to the users throughout ... designer brand or one from the local market, the makers ... exterior and, in the process, often overlook comfort and health. ... kind of shoe, the creative heads at Vay Technologies have ...
(Date:6/2/2015)... BALTIMORE, Md. – Ellarea Maria Cole Stansbury ... after being diagnosed with lupus. In spite of genetic ... which enhance health, lupus and other autoimmune related diseases ... Wellness ,” she offers a holistic approach to live ... an overview of some autoimmune diseases—especially lupus —including ...
(Date:6/2/2015)... Pleasant Prairie, WI (PRWEB) June 03, 2015 ... suited for regulated industries such as government, finance and ... any organization that wants reliable access control to enhance ... smart card keyboard requires the secondary authentication of a ... In addition to the smart-chipset card reader, the ...
Breaking Medicine News(10 mins):Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2
... in Afghanistan are increasingly suffering from war–related anxiety and ... ,Ontario’s ombudsman Andre Marin had undertaken a recent ... center for treatment of such traumatized children was caught ... bodies unwilling to take financial responsibilities. ,Mr. ...
... All India Institute of Medical Sciences (AIIMS) Director P. ... a former patient alleging// that the state-run hospital had ... undergoing treatment at its cardiac and neuro center. ... to Venugopal, Mayank Sharma, former senior financial advisor, Arti ...
... scientists have undertaken what is described as the biggest DNA ... mark the biggest single leap in the understanding of how ... to a new wave of tailored therapies and tests to ... ,A coalition of 50 groups, including 24 leading ...
... human interference may destroy much of Sundarbans in India and ... a new UNESCOreport.// ,"Sea-level rise is the greatest ... Asia. A 45 cm rise in global sea levels would ... mangroves," the report warned. ,The report, "Case Studies ...
... may be at far higher risk for eating disorders ... first population-based study of its kind, the// researchers found ... eating disorders. ,Researchers Ilan H. ... the Mailman School of Public Health and principal investigator, ...
... remains the most beneficial proven intervention for ischemic stroke, ... Guidelines for the Early Management of Adults with Ischemic ... intra-arterial administration of clot-busting drugs and mechanical removal of ... guidelines focus on the crucial first hours from the ...
Cached Medicine News:Health News:Collateral Damage-Children Of Canadian Soldiers Suffer 2Health News:Court Issues Notice to Venugopal Over Fund Irregularities 2Health News:UK Scientists to Reveal Genetic Secrets Behind Serious Illnesses 2Health News:Climate Change Threatens Sundarbans and World Heritage Sites 2Health News:Climate Change Threatens Sundarbans and World Heritage Sites 3Health News:Eating Disorders Highly Prevalent Among Gay and Bisexual Men 2Health News:Intravenous Delivery of Clot-busting Drug Still Best Intervention for Ischemic Stroke 2
Designed as an excellent form of primary suspension...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
... orthosis is designed to comfortably restrict ... allowing unobstructed motion of the fingers ... fit the splint may be trimmed ... a heat gun. One cotton stockinet ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: